{"id":460544,"date":"2020-01-10T11:20:02","date_gmt":"2020-01-10T11:20:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=460544"},"modified":"2020-01-10T11:20:02","modified_gmt":"2020-01-10T11:20:02","slug":"china-in-vitro-fertilization-market-is-projected-to-surpass-usd-28-billion-by-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/china-in-vitro-fertilization-market-is-projected-to-surpass-usd-28-billion-by-2025_460544.html","title":{"rendered":"China In Vitro Fertilization Market is projected to surpass USD 2.8 Billion by 2025"},"content":{"rendered":"
\"China<\/a><\/p>\n
\n
China In Vitro Fertilization Market is projected to surpass USD 2.8 Billion by 2025.<\/div>\n<\/div>\n<\/div>\n
China In Vitro Fertilization Market, (IVF) by Treatment (Fresh Embryo, Frozen Embryo, Donor Egg, Others), Instruments (Culture Media, Disposable Devices, Capital Equipment), Procedure (ICSI IVF, Non-ICSI IVF, IUI), End-User (Fertility Clinics, Hospitals, Others).<\/div>\n

Renub Research<\/strong> report titled “China In Vitro Fertilization Market, (IVF) by Treatment (Fresh Embryo, Frozen Embryo, Donor Egg, Others), Instruments (Culture Media, Disposable Devices, Capital Equipment), Procedure (ICSI IVF, Non-ICSI IVF, IUI), End-User (Fertility Clinics, Hospitals, Others)”<\/strong> provides a complete analysis of China In Vitro Fertilization (IVF) Market.<\/p>\n

 <\/p>\n

Every year, worldwide, thousands of cycles of in vitro fertilization (IVF) are carried out. Major factors driving the IVF sector globally are growth in the median age of motherhood, lower fertility rates, increasing male infertility due to increased use of alcohol and cigarettes, and growing public awareness of infertility and the available treatment options. For women, chances of conceiving decrease after age 32 and by age 40, rates of fertility decline by half. Likewise, for males, the amount of semen and sperm motility (the sperm’s ability to move towards an egg) declines gradually between the ages of 20 and 80. In addition, women who postpone pregnancy are at a higher risk of pregnancy-related health problems, including low birth weight, miscarriage, fetal abnormalities, premature delivery, prolonged labor and maternal morbidity. China In Vitro Fertilization Market<\/a> is projected to surpass USD 2.8 Billion<\/strong> by 2025<\/strong>.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

However, a major factor limiting the adoption of IVF treatment is the high cost of IVF procedures. Multiple births occur after 39 percent of IVF treatments, according to the Institute for Health Policy Studies at the University of California in the US, whereas in Europe they are 26 percent. However, the risk of birth after the procedure is relatively low. The IVF treatment success rate is only 28 percent to 35 percent, which declines with the woman’s age. The success rate, for instance, was 32.2% for women under 35, 27.7% for women aged 35 to 37, 20.8% for women aged 38 to 39, 13.6% for women aged 40 to 42, 5% for women aged 43 to 44, and 1.9% for women aged over 44.<\/p>\n

 <\/p>\n

Request a free sample copy of the report:<\/strong> https:\/\/www.renub.com\/request-sample-page.php?gturl=china-in-vitro-fertilization-market-p.php<\/a><\/p>\n

 <\/p>\n

Market Summary:<\/strong><\/p>\n

By Treatment:<\/strong> The China In-Vitro fertilization (IVF) is divided into four segments; Fresh Embryo, Frozen Embryo, Donor Egg and Others<\/p>\n

By End User:<\/strong> The global IVF market was segmented into fertility clinics and surgical centers, hospitals and others based on end-users. It is projected that the category of fertility clinics and surgical centers will dominate the largest share of the global market in 2018. It is also projected that this segment will record the highest CAGR over the forecast period.<\/p>\n

By Instruments:<\/strong> This report provides full market insight by instruments; Culture Media, Disposable Devices and Capital Equipment<\/p>\n

 <\/p>\n

Request a free Brochure copy of the report: <\/strong> https:\/\/www.renub.com\/request-brochure-page.php?gturl=china-in-vitro-fertilization-market-p.php<\/a><\/p>\n

 <\/p>\n

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.<\/strong><\/p>\n

 <\/p>\n

Browse Related Reports:<\/strong><\/p>\n

China Vaccine Market<\/a><\/p>\n

China Cancer Drugs Market<\/a><\/p>\n

 <\/p>\n

Contact Us<\/strong>
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com<\/p>\n

 <\/p>\n

Key Topics Covered :<\/strong><\/p>\n

1.    Introduction<\/strong><\/p>\n

2.    Research Methodology<\/strong><\/p>\n

3.    Executive Summary<\/strong><\/p>\n

4.    China In-Vitro Fertilization Market<\/strong><\/p>\n

5.    China In-Vitro Fertilization Numbers<\/strong><\/p>\n

6.    Market Share – China In-Vitro Fertilization<\/strong><\/p>\n

       6.1    By Treatment
       6.2    By Instrument
       6.3    By Procedure
       6.4    By End User<\/p>\n

 <\/p>\n

7.    Treatment – China In-Vitro Fertilization Market<\/strong><\/p>\n

       7.1    Fresh Embryo
       7.2    Frozen Embryo
       7.3    Donor Egg
       7.4    Others<\/p>\n

 <\/p>\n

8.    Instrument – China In-Vitro Fertilization Market<\/strong><\/p>\n

       8.1    Culture Media
       8.2    Disposable Devices
       8.3    Capital Equipment<\/p>\n

 <\/p>\n

9.    Procedure – China In-Vitro Fertilization Market<\/strong><\/p>\n

       9.1    ICSI IVF
       9.2    Non-ICSI IVF
       9.3    IUI<\/p>\n

 <\/p>\n

10.    End User – China In-Vitro Fertilization Market<\/strong><\/p>\n

       10.1    Fertility Clinics
       10.2    Hospitals
       10.3    Others<\/p>\n

 <\/p>\n

11.    Growth Drivers<\/strong><\/p>\n

       11.1    Delayed Pregnancies in Women
       11.2    Rise in Infertility Rates
       11.3    Surge in IVF Success Rates
       11.4    Growth in Disposable Income of Consumers<\/p>\n

 <\/p>\n

12.    Challenges<\/strong><\/p>\n

       12.1    Embryo Smuggling Cases Affecting IVF Services Market
       12.2    Unaffordable Cost of Assisted Reproductive Techniques (ART)<\/p>\n

 <\/p>\n

About Us:<\/strong><\/p>\n

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Renub Research<\/a>
Contact Person:<\/strong> Rajat Gupta
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 16783020700
Address:<\/strong>225 Kristie Ln
City:<\/strong> Roswell
State:<\/strong> GA
Country:<\/strong> United States
Website:<\/strong> www.renub.com\/life-science-1-c.php<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

China In Vitro Fertilization Market is projected to surpass USD 2.8 Billion by 2025. China In Vitro Fertilization Market, (IVF) by Treatment (Fresh Embryo, Frozen Embryo, Donor Egg, Others), Instruments (Culture Media, Disposable Devices, Capital Equipment), Procedure (ICSI IVF, Non-ICSI … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[424,405,406,420,446],"tags":[],"class_list":["post-460544","post","type-post","status-publish","format-standard","hentry","category-Family-Parenting","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-Society-Culture"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/460544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=460544"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/460544\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=460544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=460544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=460544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}